i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more
i-SENS Inc (099190) - Net Assets
Latest net assets as of September 2025: ₩345.35 Billion KRW
Based on the latest financial reports, i-SENS Inc (099190) has net assets worth ₩345.35 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩583.47 Billion) and total liabilities (₩238.13 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩345.35 Billion |
| % of Total Assets | 59.19% |
| Annual Growth Rate | 14.38% |
| 5-Year Change | 56.26% |
| 10-Year Change | 159.79% |
| Growth Volatility | 12.0 |
i-SENS Inc - Net Assets Trend (2012–2024)
This chart illustrates how i-SENS Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for i-SENS Inc (2012–2024)
The table below shows the annual net assets of i-SENS Inc from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩342.98 Billion | +13.01% |
| 2023-12-31 | ₩303.49 Billion | +6.19% |
| 2022-12-31 | ₩285.81 Billion | +6.51% |
| 2021-12-31 | ₩268.33 Billion | +22.25% |
| 2020-12-31 | ₩219.49 Billion | +10.54% |
| 2019-12-31 | ₩198.56 Billion | +9.75% |
| 2018-12-31 | ₩180.93 Billion | +11.14% |
| 2017-12-31 | ₩162.80 Billion | +8.77% |
| 2016-12-31 | ₩149.67 Billion | +13.37% |
| 2015-12-31 | ₩132.02 Billion | +11.12% |
| 2014-12-31 | ₩118.81 Billion | +13.89% |
| 2013-12-31 | ₩104.32 Billion | +52.43% |
| 2012-12-31 | ₩68.44 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to i-SENS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3558.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩208.19 Billion | 64.12% |
| Common Stock | ₩13.82 Billion | 4.26% |
| Other Components | ₩102.68 Billion | 31.62% |
| Total Equity | ₩324.70 Billion | 100.00% |
i-SENS Inc Competitors by Market Cap
The table below lists competitors of i-SENS Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Frontera Energy Corp
PINK:FECCF
|
$127.48 Million |
|
Guan Chong Bhd
KLSE:5102
|
$127.50 Million |
|
Audix Corp
TW:2459
|
$127.51 Million |
|
CMG Pharmaceutical Co. Ltd
KQ:058820
|
$127.53 Million |
|
Double Bond Chemical Ind Co Ltd
TW:4764
|
$127.37 Million |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
$127.35 Million |
|
Guangzhou Jinyi Media Corp
SHE:002905
|
$127.34 Million |
|
Zhejiang Lianxiang Smart Home
SHG:603272
|
$127.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in i-SENS Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 284,350,130,110 to 324,695,034,190, a change of 40,344,904,080 (14.2%).
- Net loss of 1,794,053,580 reduced equity.
- Dividend payments of 2,750,849,600 reduced retained earnings.
- Share repurchases of 2,009,372,450 reduced equity.
- New share issuances of 2,009,372,450 increased equity.
- Other factors increased equity by 44,889,807,260.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-1.79 Billion | -0.55% |
| Dividends Paid | ₩2.75 Billion | -0.85% |
| Share Repurchases | ₩2.01 Billion | -0.62% |
| Share Issuances | ₩2.01 Billion | +0.62% |
| Other Changes | ₩44.89 Billion | +13.83% |
| Total Change | ₩- | 14.19% |
Book Value vs Market Value Analysis
This analysis compares i-SENS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.92x to 1.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩10909.12 | ₩21000.00 | x |
| 2017-12-31 | ₩11854.11 | ₩21000.00 | x |
| 2018-12-31 | ₩13308.31 | ₩21000.00 | x |
| 2019-12-31 | ₩14605.48 | ₩21000.00 | x |
| 2020-12-31 | ₩16145.03 | ₩21000.00 | x |
| 2021-12-31 | ₩9868.73 | ₩21000.00 | x |
| 2022-12-31 | ₩10407.06 | ₩21000.00 | x |
| 2023-12-31 | ₩10336.81 | ₩21000.00 | x |
| 2024-12-31 | ₩11748.14 | ₩21000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently i-SENS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.62%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.82x
- Recent ROE (-0.55%) is below the historical average (9.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 12.78% | 13.14% | 0.72x | 1.34x | ₩1.90 Billion |
| 2013 | 18.08% | 22.50% | 0.59x | 1.37x | ₩8.33 Billion |
| 2014 | 12.30% | 15.13% | 0.58x | 1.39x | ₩2.71 Billion |
| 2015 | 11.15% | 14.44% | 0.57x | 1.36x | ₩1.51 Billion |
| 2016 | 11.73% | 13.26% | 0.62x | 1.44x | ₩2.59 Billion |
| 2017 | 9.66% | 10.02% | 0.67x | 1.44x | ₩-549.13 Million |
| 2018 | 12.50% | 13.07% | 0.69x | 1.39x | ₩4.53 Billion |
| 2019 | 11.80% | 12.34% | 0.70x | 1.36x | ₩3.57 Billion |
| 2020 | 12.23% | 13.18% | 0.66x | 1.40x | ₩4.89 Billion |
| 2021 | 9.48% | 10.93% | 0.54x | 1.60x | ₩-1.38 Billion |
| 2022 | 5.65% | 6.09% | 0.59x | 1.57x | ₩-12.44 Billion |
| 2023 | 1.30% | 1.40% | 0.53x | 1.75x | ₩-24.73 Billion |
| 2024 | -0.55% | -0.62% | 0.49x | 1.82x | ₩-34.26 Billion |
Industry Comparison
This section compares i-SENS Inc's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $88,877,757,476
- Average return on equity (ROE) among peers: -8.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| i-SENS Inc (099190) | ₩345.35 Billion | 12.78% | 0.69x | $127.37 Million |
| InBody Co.Ltd (041830) | $183.73 Billion | 18.52% | 0.11x | $208.16 Million |
| MEDIANA Co.Ltd (041920) | $34.91 Billion | 20.29% | 0.27x | $70.69 Million |
| Value Added Technology Co. Ltd (043150) | $349.29 Billion | 22.01% | 0.46x | $109.99 Million |
| MEKICS Co Ltd (058110) | $7.87 Billion | -24.74% | 1.89x | $14.44 Million |
| Meta Biomed Co. Ltd (059210) | $39.05 Billion | 3.02% | 0.38x | $50.83 Million |
| INFINITT Healthcare Co. Ltd (071200) | $77.28 Billion | 6.38% | 0.20x | $53.10 Million |
| Sewoon Medical Co. Ltd (100700) | $46.71 Billion | 7.88% | 0.18x | $34.07 Million |
| CU Medical Systems Inc (115480) | $58.36 Billion | 16.15% | 0.51x | $14.81 Million |
| PeopleBio Inc (304840) | $2.70 Billion | -148.07% | 0.61x | $5.72 Million |